常山药业：艾本那肽上市申请如有重大进展，公司会根据有关规则予以公告

Group 1 - The company, Changshan Pharmaceutical, stated on October 21 that it will announce any significant progress regarding the上市申请 (listing application) for Aibennapeptide according to relevant regulations [2]